Press "Enter" to skip to content

Sputnik V Imported To Cost Rs 995 Per Shot, First Dose Administered



The first dose of Sputnik V was administered in Hyderabad as a part of a restricted pilot, mushy launch.


  • First dose administered in Hyderabad at this time as a part of mushy launch
  • Sputnik V has an effectivity of 91.6%, third vaccine cleared in India
  • Dr Reddy’s Laboratories is the Indian producer of the Russian vaccine

New Delhi:

An imported dose of Russia’s Sputnik V coronavirus vaccine towards will price Rs. 995.40 in India, Dr Reddy’s Laboratories, which is manufacturing the vaccine in India, mentioned at this time. Sputnik V, which has an effectivity of 91.6 per cent, is the third vaccine to be authorized to be used in India.

The first dose of the vaccine was administered in Hyderabad at this time as a part of a mushy launch by Dr Reddy’s.

The worth of the imported doses will embody 5 per cent GST per dose. Doses of Sputnik V that are made in India, nevertheless, are more likely to be cheaper.

The vaccine is more likely to be out there out there from subsequent week, the Centre had mentioned on Thursday because the vaccine scarcity in numerous states deepened and restrictions have been introduced in for vaccination.

The first consignment of imported doses of the Sputnik V vaccine landed in India on May 1, after it was cleared for emergency use in India on April 13.

“Further consignments of imported doses are expected over the upcoming months. Subsequently, supply of the Sputnik V vaccine will commence from Indian manufacturing partners,” Dr Reddy’s mentioned.

At 91.6 per cent, Sputnik V has a better efficacy in comparison with the 2 Covid vaccines which might be at present being administered in India: Oxford-AstraZeneca’s Covishield, manufactured by the Serum Institute of India, and Bharat Biotech’s Covaxin.

Writing in medical journal The Lancet, scientists concerned in a peer-review of the vaccine have mentioned, ”Notwithstanding the earlier points and lack of transparency, the interim outcomes from the section three trial of the Sputnik V vaccine once more increase critical considerations.”

The allegations have been countered by Russian scientists in one other piece in The Lancet. The scientists mentioned, ”Clear and clear regulatory requirements exist for provision of scientific trial knowledge.” 

Sputnik V is considered one of solely three vaccines on the planet with such a excessive efficacy price, after Pfizer and Moderna vaccines. The two-dose vaccine additionally has most authorisations granted globally. Priced at lower than $10 per dose in worldwide markets, the vaccine has already been administered to greater than 20 lakh individuals worldwide.

The Sputnik vaccine is on the market in each liquid and powder kind. The liquid kind must be saved at minus 18 levels. For the powder kind – which will be stored between two and eight levels, stability assessments are ongoing.

In September final yr, Dr Reddy’s partnered with the Russian Direct Investment Fund (RDIF) to conduct scientific trials of Sputnik V and for its distribution rights in India.

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: